How much does it cost to hire a lawyer for my case?

Nothing up front. Your case is handled on a contingency-fee basis — there are no attorney's fees unless your case results in a recovery.

Is there a deadline to file?

Yes. Every state's statute of limitations strictly limits the time you have to file. In many states the clock starts on the date of injury or diagnosis. Do not wait — once the deadline passes, your claim is permanently barred.

Will my case be a class action?

No. GLP-1 cases are consolidated as Multidistrict Litigation (MDL 3094) in the Eastern District of Pennsylvania. Each plaintiff keeps an individual claim and any settlement is based on individual injuries.

GLP-1 Drug Injury

Mounjaro vs Zepbound: Plain-English Comparison

Mounjaro and Zepbound are the same molecule — tirzepatide, from Eli Lilly — sold under two labels for two indications. If you took either one and were hospitalized, both qualify for the GLP-1 litigation.

Call (717) 724-7503

Indications

Mounjaro is approved for type 2 diabetes. Zepbound is approved for chronic weight management. Both use tirzepatide, a dual GLP-1/GIP receptor agonist. Dosing schedules and titration are similar.

Side-effect profile

Tirzepatide slows gastric emptying even more profoundly than semaglutide in some studies. Severe gastroparesis, ileus, pancreatitis, and gallbladder disease are all reported with both Mounjaro and Zepbound.

Eligibility for MDL 3094

Either Mounjaro or Zepbound use, combined with a qualifying injury, supports filing in the consolidated federal litigation against Eli Lilly. Pharmacy records identify which brand you used.

Frequently Asked Questions

Get your free, confidential case review

Takes under 60 seconds. No fee unless you win.